期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Can spot urine measurement be a substitute for 24-hour urine measurement to estimate sodium intake in adolescents?
1
作者 Jie Dong Xiaoyuan Zhao +2 位作者 Hongbo Dong Yinkun Yan Jie Mi 《Pediatric Investigation》 CSCD 2021年第1期12-20,共9页
Importance:Several methods have been established in recent decades that allow use of spot urine to estimate dietary sodium intake.However,their accuracies have been controversial in children.Objective:To validate the ... Importance:Several methods have been established in recent decades that allow use of spot urine to estimate dietary sodium intake.However,their accuracies have been controversial in children.Objective:To validate the performance of three commonly used methods-the Kawasaki,Tanaka,and International Cooperative Study on Salt,Other Factors,and Blood Pressure(INTERSALT)methods.Additionally,this study explored the accuracies of the Tanaka and INTERSALT methods by using spot urine samples taken at four separate times.Method:Forty-one adolescents aged 14 to 16 years completed two non-consecutive 24-hour urine collections and their mean values were used as reference data.The second-morning urine was used for assessment with the Kawasaki method;a casual spot urine and spot urine samples taken at four separate times(morning,afternoon,evening,and overnight)were used for assessment with the Tanaka and INTERSALT methods.Results:The mean differences were 1801 mg,542 mg,47 mg,and-31 mg for the Kawasaki,Tanaka,INTERSALT 1(with potassium),and INTERSALT2(without potassium)methods with their required spot urine,respectively.The proportions of relative difference levels within±10%were 4.9%for the Kawasaki method,19.5%for the Tanaka method,36.6%for the INTERSALT 1 method,and 36.6%for the INTERSALT2 method.Interpretation:The INTERSALT method seemed to provide minimally biased estimations of mean population sodium intake with casual spot urine.However,there is a need to be cautious regarding inconsistencies in estimation among different levels of sodium intake.The methods assessed in this study were unable to accurately estimate sodium intake at the individual level. 展开更多
关键词 Adolescents Spot urine Sodium 24-hour urine
原文传递
肝豆状核变性患者血清超氧化物歧化酶活性水平变化及与年龄、病程、尿酸和24 h尿铜的相关性
2
作者 夏昆 韩永升 +7 位作者 艾文龙 王玉 朱玉龙 孙丹丹 付晓明 叶群荣 李凯 杨任民 《吉林医学》 CAS 2022年第11期2928-2933,共6页
目的:观察肝豆状核变性(HLD)患者血清超氧化物歧化酶(SOD)活性水平的变化特点,并分析血清SOD活性水平与患者年龄、病程、尿酸和24 h尿铜的相关性。方法:回顾性分析500例HLD住院患者,参照2015年杨任民等制定的HLD分型标准,对入组患者的... 目的:观察肝豆状核变性(HLD)患者血清超氧化物歧化酶(SOD)活性水平的变化特点,并分析血清SOD活性水平与患者年龄、病程、尿酸和24 h尿铜的相关性。方法:回顾性分析500例HLD住院患者,参照2015年杨任民等制定的HLD分型标准,对入组患者的性别、年龄、病程、临床分型、肝脏分型和临床分级进行分类与统计,并统计患者驱铜治疗前血清SOD活性水平、尿酸(UA)水平、驱铜治疗前24 h尿铜(疗前24 h尿铜)和二巯基丙磺酸钠驱铜治疗第1个疗程第2天的24 h尿铜(疗后24 h尿铜),分析并比较不同性别、年龄、病程、临床分型、肝脏分型和临床分级的HLD患者血清SOD活性水平差异,同时分析血清SOD活性水平与患者年龄、病程、UA、疗前24 h尿铜和疗后24 h尿铜的相关性。结果:500例HLD患者中,25例血清SOD活性降低,136例血清SOD活性升高,总异常率为32.2%。男、女性别间的血清SOD活性水平比较,差异无统计学意义(P>0.05)。不同年龄分组、病程分组、临床分型、肝脏分型、临床分级的HLD患者的血清SOD活性水平差异具有统计学意义(P<0.05)。其中,年龄分组1~10岁组患者血清SOD活性水平最高,51~60岁组患者最低;病程分组6~10年组患者血清SOD活性水平最高,21~30年组患者最低;临床分型症状前期型患者血清SOD活性水平最高,脑-内脏型患者最低;肝脏分型轻微病变型患者血清SOD活性水平最高,结节型患者最低,患者血清SOD活性水平随着肝脏损伤程度的加重,呈逐渐下降趋势;临床分级0级患者血清SOD活性水平最高,Ⅳ级患者最低,患者血清SOD活性水平随着临床分级等级的升高,呈逐渐下降趋势。HLD患者血清SOD活性水平与年龄、病程及24 h尿铜之间成负相关关系,差异有统计学意义(P<0.05),与UA之间成正向相关关系,差异有统计学意义(P<0.05)。结论:HLD患者存在血清SOD活性水平的异常变化,血清SOD活性水平与患者年龄、病程、24 h尿铜成负相关性,与UA成正相关性。此外,血清SOD活性水平受到HLD患者疾病损害程度的影响,随着HLD患者疾病损害程度的加重,其血清SOD活性水平逐渐下降,通过观察HLD患者的血清SOD活性水平,对患者病情严重程度的初步判断有一定的临床指导价值。 展开更多
关键词 肝豆状核变性 血清超氧化物歧化酶 尿酸 24 h尿铜
下载PDF
补中益气汤对阿霉素诱导的大鼠肾病的作用 被引量:2
3
作者 郭继光 张海燕 +2 位作者 李朝鹏 高飒 李芸 《河北大学学报(自然科学版)》 CAS 北大核心 2015年第3期298-304,共7页
以阿霉素肾病大鼠模型为研究对象,采用了血液生化学和组织病理学方法,分析了补中益气汤对阿霉素肾病的作用和可能的机制.Wistar雄性大鼠60只,随机分为对照组(n=10)、模型组(n=10)、激素组(n=10)和补中益气汤低剂量组(n=10)、中剂量组(n=... 以阿霉素肾病大鼠模型为研究对象,采用了血液生化学和组织病理学方法,分析了补中益气汤对阿霉素肾病的作用和可能的机制.Wistar雄性大鼠60只,随机分为对照组(n=10)、模型组(n=10)、激素组(n=10)和补中益气汤低剂量组(n=10)、中剂量组(n=10)和高剂量组(n=10).采用阿霉素二次尾静脉注射法(首次6mg/kg,二次3mg/kg)制作阿霉素肾病的大鼠模型.在阿霉素注射后7,21,42d将大鼠置于代谢笼中分别收集24h尿液,测定24h尿蛋白.末次给药后,眼眶取血检测肾功能指标,包括肌肝SCR(serum creatine)和尿素氮BUN(blood urea nitrogen);处死大鼠并观察肾组织病理改变.结果表明:补中益气汤可以显著减少尿蛋白的排泄并缓解肾皮质上皮细胞的病理学改变.这提示补中益气汤对阿霉素大鼠能够通过改善尿蛋白的排泄,缓解肾脏病理改变,从而起到对肾脏的保护作用. 展开更多
关键词 阿霉素肾病 补中益气汤 24 h尿蛋白 肌酐 尿素氮 24-hour urine protein (24 HUP)
下载PDF
肝豆汤治疗湿热内蕴型肝豆状核变性吞咽功能障碍的临床研究 被引量:10
4
作者 陶庄 汪美霞 孙林娟 《中西医结合心脑血管病杂志》 2021年第1期32-34,共3页
目的观察肝豆汤治疗肝豆状核变性吞咽功能障碍的临床疗效。方法选取2018年12月—2019年7月安徽中医药大学第一附属医院脑病中心的住院病人80例,随机分为观察组和对照组,各40例;对照组给予吞咽训练、静脉输注二巯丙磺酸钠常规排铜治疗,... 目的观察肝豆汤治疗肝豆状核变性吞咽功能障碍的临床疗效。方法选取2018年12月—2019年7月安徽中医药大学第一附属医院脑病中心的住院病人80例,随机分为观察组和对照组,各40例;对照组给予吞咽训练、静脉输注二巯丙磺酸钠常规排铜治疗,观察组在对照组基础上加用肝豆汤治疗,连续治疗6 d为1个疗程,共治疗4个疗程。比较两组治疗前、治疗2个疗程末及4个疗程末吞咽评价量表评分、中医证候量表评分、24 h尿铜水平。结果治疗4个疗程后,观察组临床疗效总有效率高于对照组(65.0%与47.5%,P<0.05)。治疗2个疗程末及4个疗程末,观察组中医证候积分、吞咽评价量表评分较治疗前明显改善(P<0.05或P<0.01),且观察组中医证候积分、吞咽评价量表评分均较对照组明显改善(P<0.05或P<0.01)。治疗2个疗程末及4个疗程末,两组24 h尿铜较治疗前明显升高(P<0.01),治疗4个疗程末,观察组24 h尿铜均较对照组明显升高(P<0.01)。结论肝豆汤能改善湿热内蕴型肝豆状核变性吞咽功能障碍症状、中医证候积分、吞咽评价量表评分和24 h尿铜水平。 展开更多
关键词 肝豆状核变性 湿热内蕴型 吞咽功能障碍 肝豆汤 中医证候 24 h尿铜
下载PDF
Association between endogenous cortisol level and the risk of central serous chorioretinopathy:a Meta-analysis 被引量:2
5
作者 Zhi-Qiao Liang Lyu-Zhen Huang +1 位作者 Jin-Feng Qu Ming-Wei Zhao 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第2期296-300,共5页
AIM: To assess the association between endogenous cortisol level and the risk of central serous chorioretinopathy(CSC).METHODS: Case-control studies were systematically searched on PubM ed, Embase, Cochrane, China... AIM: To assess the association between endogenous cortisol level and the risk of central serous chorioretinopathy(CSC).METHODS: Case-control studies were systematically searched on PubM ed, Embase, Cochrane, China National Knowledge Infrastructure(CNKI) for publishes between January 1990 and July 2017 to assess the association between endogenous cortisol level and CSC. The main endpoints were serum cortisol level at 8 a.m. and 24-hour urine 17-hydroxysteroids level. We assessed pooled data using a random-effects model.RESULTS: Of 86 identified studies, 5 were eligible included in our analysis. The 5 studies included a total of 315 participants, of whom 187 had CSC. Statistically significant association was observed between serum cortisol level(summary SMD=0.77, 95%CI=0.55-0.99), 24-hour urine 17-hydroxysteroids level(summary SMD=0.95, 95%CI=0.61-1.30), and the risk of CSC.CONCLUSION: Endogenous cortisol level is associated with an increased risk of CSC. Combined treatment targeting the serum cortisol level at 8 a.m. and 24-hour urine 17-hydroxysteroids level can be a potential preventive strategy for individuals who are at risk of CSC and therapeutic strategy for patients with CSC. 展开更多
关键词 endogenous cortisol central serous chorioretinopathy serum cortisol 24-hour urine 17-hydroxysteroids Meta-analysis
下载PDF
44例肝豆状核变性患者临床特征、辅助检查结果及疗效评价
6
作者 章仁华 江凯 陈永莹 《肝脏》 2022年第12期1318-1321,共4页
目的汇总44例肝豆状核变性(HLD)患者临床特征、辅助检查结果及疗效等病历资料,旨在加强对该病的认识。方法收集2007年2月—2021年10月期间HLD患者44例(男28例、女16例),年龄(9.3±3.4)岁,年龄2~17岁。HLD符合诊断要求。根据年龄阶段... 目的汇总44例肝豆状核变性(HLD)患者临床特征、辅助检查结果及疗效等病历资料,旨在加强对该病的认识。方法收集2007年2月—2021年10月期间HLD患者44例(男28例、女16例),年龄(9.3±3.4)岁,年龄2~17岁。HLD符合诊断要求。根据年龄阶段,分为学龄前期(<7岁)、学龄期(7~12岁)及青少年期(>12岁);依据诊断指南分为不同临床类型。结果44例HLD患儿学龄前期、学龄期及青少年期分别为6例(13.6%)、34例(77.3%)及4例(9.1%);肝型、脑型、混合型及其他类型分别26例(59.1%)、6例(13.6%)、6例(13.6%)及6例(13.6%),其中各型起病年龄为(8.4±2.0)岁、(11.2±1.2)岁、(10.4±2.2)岁及(10.5±1.9)岁,肝型年龄显著低于其他类型(P<0.05)。HLD患者首诊症状以肝脏部位多见,其中以肝酶异常(升高)病例最多。HLD患儿K-F环阳性、血铜蓝蛋白阳性、24h尿铜阳性及腹部超声异常分别为33例(75.0%)、43例(97.7%)、43例(97.7%)及38例(83.4%)。学龄前期K-F环阳性率(0%)显著低于学龄期(85.3%)、青少年期(100%)(χ^(2)=18.610,10.000,P<0.05);学龄前期腹部超声异常率(33.3%)显著低于学龄期(94.1%)、青少年期(100%)(χ^(2)=14.779,4.444,P<0.05);肝型K-F环阳性率(57.7%)显著低于其他临床类型(均为100%)(χ^(2)均为3.868,P<0.05)。按照治疗方式的不同,HLD患儿中锌剂、青霉胺联合锌剂治疗分别为18例、26例。比较资料可知,两组治疗前24 h尿铜、肝酶正常时24 h尿铜及复发率等差异具有统计学意义(t=8.042,14.150,χ^(2)=4.011,P<0.05)。结论HLD患儿临床症状常不典型,个体差异较大,以肝脏症状最为突出。肝型、学龄前期HLD患者K-F环阳性率、腹部彩超异常率显著低于其他组病例。单独应用锌剂或联合青霉胺治疗均对HLD有效,治疗方案优化还需要进一步探究。 展开更多
关键词 肝豆状核变性 K-F环 血铜蓝蛋白 24 h尿铜
下载PDF
Nutritional Biomarker Analyses for Hypertension-Related Risk Assessment and Control
7
作者 Mari Mori Hideki Mori Yukio Yamori 《World Journal of Cardiovascular Diseases》 2014年第5期268-276,共9页
A simple method to collect 24-hour urine (24U) by sampling 2.5% of the voided urine each time was developed for analyzing the biomarkers of the intakes of salt (NaCl), vegetables and grains (K, Mg), soys (isoflavones)... A simple method to collect 24-hour urine (24U) by sampling 2.5% of the voided urine each time was developed for analyzing the biomarkers of the intakes of salt (NaCl), vegetables and grains (K, Mg), soys (isoflavones), sea-foods (taurine), protein (urea nitrogen) etc. This method was applied to WHO-coordinated CARDIAC (Cardiovascular Diseases and Alimentary Comparison) study covering 61 populations in 25 countries, and revealed significant positive associations of Na or Na/K with blood pressure (BP) and stroke mortality and significant inverse associations of isoflavones or taurine with coronary heart disease (CHD) mortality, indicating the adverse effect of salt intake on BP and stroke and beneficial effect of soy or sea food intakes on CHD. Furthermore, higher urinary taurine and/or Mg excretions were associated with significantly lower risks of metabolic syndromes such as obesity, hypertension and hypercholestelomia. 24U collections were useful to prove nutritional improvement by intervention studies for observing soy intake effect on BP and atherogenic index in Japanese immigrants living in Brazil, and in Australian Aboriginals, for observing taurine effect on BP in Tibetans and for confirming soy and fish effects on the risks of metabolic syndromes in Japanese businessmen. 24U collection was utilized for population strategy to reduce salt and to increase soy intake in 5.6 million people of Hyogo Prefecture. A simple method for 24U collection has enabled us to utilize nutritional biomarkers for hypertension-related disease risk analyses, and to apply objective nutritional intake estimation to intervention studies as well as to population strategy for nutritional improvement, and therefore, the methodology will contribute to hypertension-related disease prevention and global health promotion. 展开更多
关键词 24-hour urine Sodium TAurine ISOFLAVONE Magnesium
下载PDF
肝豆灵片治疗肝豆状核变性痰瘀互结证的疗效观察 被引量:29
8
作者 徐磊 蔡永亮 +5 位作者 蒋怀周 王艳昕 韩辉 侯志峰 马守亮 徐明安 《中国实验方剂学杂志》 CAS CSCD 北大核心 2017年第15期173-177,共5页
目的:观察肝豆灵片治疗肝豆状核变性痰瘀互结证的疗效,并探讨其作用机制。方法:将76例肝豆状核变性痰瘀互结证患者随机分为对照组和观察组,各38例,两组均给予西医基础治疗[二巯基丙磺酸钠(DMPS)和葡萄糖酸锌片],观察组加用肝豆灵片,治疗... 目的:观察肝豆灵片治疗肝豆状核变性痰瘀互结证的疗效,并探讨其作用机制。方法:将76例肝豆状核变性痰瘀互结证患者随机分为对照组和观察组,各38例,两组均给予西医基础治疗[二巯基丙磺酸钠(DMPS)和葡萄糖酸锌片],观察组加用肝豆灵片,治疗6个疗程后观察两者临床疗效。观察治疗前后两组中医证候积分,改良Goldstein分级,24 h尿铜(urine copper,u-Cu),游离铜(non-ceruloplasmin plasma copper,nCP-Cu)水平、肝功能和血常规等指标。结果:中医证候疗效总有效率对照组为60.53%,观察组为81.58%,观察组优于对照组(P<0.01)。临床疗效总有效率对照组为73.68%,观察组为84.21%,观察组优于对照组(P<0.05)。与治疗前比较,治疗后两组患者n CP-Cu水平明显降低(P<0.05),u-Cu水平显著升高(P<0.01);治疗后两组无统计学差异。与治疗前比较,两组患者血清总胆红素(total bilirubin,TBIL),天门冬氨酸氨基转移酶(aspartate aminotransferase,AST)和丙氨酸氨基转移酶(alanine amino-transferase,ALT)水平显著降低(P<0.01);治疗后与对照组比较,观察组TBIL,AST和ALT水平明显降低(P<0.05)。结论:肝豆灵片能显著改善肝豆状核变性痰瘀互结证患者中医证候,提高临床疗效,同时改善肝功能,且安全性高。 展开更多
关键词 肝豆灵片 肝豆状核变性 痰瘀互结证 二巯基丙磺酸钠 24 h尿铜 游离铜 肝功能
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部